# EE497 The Cost-Effectiveness of Semaglutide 2.4MG in Patients With Overweight/Obesity and Cardiovascular Disease From the Select Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/ee497-the-cost-effectiveness-of-semaglutide-2-4mg-in-patients-with-overweight/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Phil McEwan,Martin Bøg,Mads Faurby,V. Foos,Ildiko Lingvay,Christopher Lübker,Robert Miller,Joshua C. Toliver,Florian Yeates,A. Michael Lincoff |
| Citations | 3 |
| DOI | 10.1016/j.jval.2024.03.2261 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4399706230 |
| Type | conference-abstract |
| Year | 2024 |

## Paper authors

- [Christopher Lübker](https://scholariq.org/researchers/christopher-lubker/)

## Paper journal

- [Value in Health](https://scholariq.org/journals/value-in-health/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.